Human Trials Set for Experimental HIV Vaccine
The vaccine targets a vulnerable site on HIV -- the virus that causes AIDS -- and triggered antibody production in mice, guinea pigs and monkeys, according to researchers with the U.S. National Institute of Allergy and Infectious Diseases (NIAID).
Source: WebMD Health - Category: Consumer Health News Source Type: news
More News: AIDS Vaccine | Allergy | Allergy & Immunology | Guinea Health | Health | HIV AIDS | Infectious Diseases | Vaccines